A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. [electronic resource]
Producer: 19951114Description: 2236-44 p. digitalISSN:- 0009-7322
- Aged
- Aprotinin -- administration & dosage
- Blood Loss, Surgical -- prevention & control
- Blood Transfusion
- Blood Volume
- Coronary Artery Bypass
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Hemostatics -- administration & dosage
- Humans
- Incidence
- Male
- Middle Aged
- Myocardial Infarction -- epidemiology
- Postoperative Complications -- epidemiology
- Prospective Studies
- Renal Insufficiency -- epidemiology
- Reoperation
- Risk Factors
- Serine Proteinase Inhibitors -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.